LianBio announces departure of President and Chief Strategy Officer Debra Yu

LianBio announced that Debra Yu, LianBio’s, has resigned from the Company, effective January 1, 2023, to pursue other business and professional interests and opportunities. To facilitate her transition, Yu entered into a consulting agreement with LianBio effective January 1, 2023, through June 30, 2023. Yu joined the Company when LianBio was first established in 2019. She has been a valued member of LianBio’s executive team and an integral part of LianBio’s transformation from an early-stage startup into a late clinical stage biotechnology company.